A群鏈球菌 (GAS) 核酸 (NA) 檢驗產品的分子診斷市場 - 歐洲的產業分析、規模、佔有率、成長、趨勢及未來預測
Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023
|出版商||Transparency Market Research||商品編碼||357899|
|出版日期||內容資訊||英文 64 Pages
|A群鏈球菌 (GAS) 核酸 (NA) 檢驗產品的分子診斷市場 - 歐洲的產業分析、規模、佔有率、成長、趨勢及未來預測 Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023|
|出版日期: 2016年04月22日||內容資訊: 英文 64 Pages||
本報告提供歐洲的A群鏈球菌 (GAS) 核酸 (NA) 檢驗產品的分子診斷市場相關調查，市場現狀與未來發展預測，各技術，各終端用戶，各地區趨勢，及參與企業簡介彙整。
Title: Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products (Polymerase chain reaction, Non-amplified tests, and Isothermal nucleic acid amplification technology; Hospitals, Public health laboratories, and Others) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023.
Nucleic acid tests are used for rapid and accurate identification of microbes. This report on molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test products in Europe analyses the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. This section also provides the overall information and data analysis of the nucleic acid test products market in Europe with respect to the leading market segments based on type of test techniques, end-user, and geography.
The market overview section of the report includes qualitative analysis of the nucleic acid test product market in Europe including the factors determining the market dynamics such as drivers, restraints, and opportunities, along with Porter's Five Forces Analysis. In addition, various analyses such as market attractiveness analysis by geography and competitive landscape by key players have been provided. The market attractiveness analysis explains the intensity of competition in the market in different geographies. The competitive scenario between market players is evaluated through market share analysis. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their shares in the European market.
The nucleic acid test product market in Europe has been segmented based on type of test technique, end-user, and geography. Based on type of test technique, the nucleic acid test market has been categorized into three major segments: polymerase chain reaction, non-amplified tests, and isothermal nucleic acid amplification technology. Based on end-user, the nucleic acid test product market in Europe has been segmented into five types: Hospitals, public health laboratories, and others. Market revenue in terms of US$ Mn for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 is provided for all the segments, considering 2014 as the base year.
Geographically, the nucleic acid test product market in Europe has been categorized into five regions: Western Europe, Northern Europe, Southern Europe, Eastern Europe, and Rest of Europe. Western Europe comprises France, Germany, Austria, and Rest of Western Europe. Northern Europe includes Ireland, Norway, Sweden, the U.K. and Northern Ireland, and Rest of Central Europe. Southern Europe comprises Italy, Spain, Portugal, and Rest of Southern Europe. Eastern Europe comprises Poland, the Czech Republic, Ukraine, Russian Federation, and Rest of Eastern Europe. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the market. The report also profiles major players in the nucleic acid test product market in Europe based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Alere, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Meridian Bioscience, Inc., Nanosphere, Inc., and Quidel Corporation.
The molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) tests in Europe has been segmented as follows: